侯旭奔
-
副教授
博士生导师
硕士生导师
- 性别:男
- 出生日期:1990-03-22
- 毕业院校:山东大学
- 学历:研究生(博士后)
- 学位:医学博士学位
- 在职信息:在职
- 所在单位:药学院
- 入职时间: 2018-12-18
- 学科:药物化学
- 办公地点:趵突泉校区景蓝斋
大学科技园3号楼1514室
- 联系方式:hxb@email.sdu.edu.cn
- 电子邮箱:hxb@email.sdu.edu.cn
访问量:
-
[21]
Reham M Elhassan.
Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug di.
Medicinal Research Reviews,
42,
1064,
2022.
-
[22]
郭永真.
Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
Mini-Reviews in Medicinal Chemistry,
21,
1367,
2021.
-
[23]
李雯.
Recent Advances in Small Molecule PROTACs for the Treatment of Cancer.
Current Medicinal Chemistry,
28,
4893,
2021.
-
[24]
赵雲鹏.
Recent Development of Novel HDAC6 Isoform-selective Inhibitors.
Current Medicinal Chemistry,
28,
4133,
2021.
-
[25]
范颖.
Recent Advances in the Development of Selective Mcl-1 Inhibitors for the Treatment of Cancer (2017-P.
Recent Patents on Anti-Cancer Drug Discovery,
15,
306,
2020.
-
[26]
梁翰之.
Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy.
EXPERT OPINION ON INVESTIGATIONAL DRUGS,
30,
61,
2021.
-
[27]
Zhao, Jing.
Substrate interaction inhibits gamma-secretase production of amyloid-beta peptides.
chemical communications,
56,
2578,
2020.
-
[28]
杜金童.
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecu.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
28,
2020.
-
[29]
周易.
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for .
《Journal of Medicinal Chemistry》,
63,
4701,
2020.
-
[30]
侯旭奔.
Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed c.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
190,
2020.
-
[31]
梁啸.
Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one.
BIOORGANIC CHEMISTRY,
103,
2020.
-
[32]
梁涛.
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells.
《Journal of Medicinal Chemistry》,
63,
12083,
2020.
-
[33]
肖鹏 , 方浩 and 侯旭奔.
Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one.
Bioorg Chem.,
2020.
-
[34]
方浩 , 侯旭奔
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecu.
Bioorganic&MedicinalChemistry,
28,
2020.
-
[35]
杨新颖 , 方浩 and 侯旭奔.
Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
EUR J MED CHEM,
191,
2020.
-
[36]
李康帅.
Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatas.
294,
8653,
2019.
-
[37]
侯旭奔 , 杨新颖 , 方浩 and 梁涛.
Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Se.
ACS Medicinal Chemistry Letters,
10,
1122,
2019.
-
[38]
杨新颖 , 方浩 , 侯旭奔 and 陈晨.
Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matri.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
2019.
-
[39]
杨新颖 , 方浩 , 侯旭奔 and 陈晨.
Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dua.
Bioorganic and medicinal chemistry,
2019.
-
[40]
杨新颖 , 侯旭奔 and 方浩.
High-performance liquid chromatographic enantioseparation of 3,5-disubstituted hydantoins analogs an.
Journal of Chromatography A,
2014.